Baker Brothers Advisors - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 87 filers reported holding SUMMIT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.92 and the average weighting 0.0%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,872,685
-62.9%
3,140,473
-50.2%
0.03%
-63.0%
Q2 2023$15,824,810
+43.4%
6,304,7050.0%0.09%
+53.3%
Q1 2023$11,033,234
+29.8%
6,304,705
+215.2%
0.06%
+17.6%
Q4 2022$8,500,0002,000,0000.05%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Baker Brothers Advisors 6,304,705$15,824,8100.09%
Virtus ETF Advisers LLC 55,763$139,9650.08%
VANCE WEALTH, INC. 39,266$98,5580.04%
CSS LLC/IL 266,514$668,9500.04%
SHELL ASSET MANAGEMENT CO 322,738$8100.03%
Steward Partners Investment Advisory, LLC 600,000$1,506,0000.02%
Alpine Global Management, LLC 30,000$75,3000.02%
SECTORAL ASSET MANAGEMENT INC 50,000$125,5000.02%
BENDER ROBERT & ASSOCIATES 24,059$60,3880.02%
HoyleCohen, LLC 74,408$186,7650.02%
View complete list of SUMMIT THERAPEUTICS INC shareholders